Fusogenic oncolytic vaccinia virus enhances systemic antitumor immune response by modulating the tumor microenvironment

被引：0
|
作者：
Nakamura, Takafumi [1 ]
机构：
[1] Tottori Univ, Sch Med, Div Mol Med, Tottori, Japan
来源：
CANCER SCIENCE | 2021年 / 112卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OE21-1-3
引用
收藏
页码：579 / 579
页数：1
相关论文
共 50 条
  • [21] An oncolytic virus expressing a full-length antibody enhances antitumor innate immune response to glioblastoma
    Bo Xu
    Lei Tian
    Jing Chen
    Jing Wang
    Rui Ma
    Wenjuan Dong
    Aimin Li
    Jianying Zhang
    E. Antonio Chiocca
    Balveen Kaur
    Mingye Feng
    Michael A. Caligiuri
    Jianhua Yu
    Nature Communications, 12
  • [22] Antiangiogenic Arming of an Oncolytic Vaccinia Virus Enhances Antitumor Efficacy in Renal Cell Cancer Models
    Guse, Kilian
    Sloniecka, Marta
    Diaconu, Iulia
    Ottolino-Perry, Kathryn
    Tang, Nan
    Ng, Calvin
    Le Boeuf, Fabrice
    Bell, John C.
    McCart, J. Andrea
    Ristimaki, Ari
    Pesonen, Sari
    Cerullo, Vincenzo
    Hemminki, Akseli
    JOURNAL OF VIROLOGY, 2010, 84 (02) : 856 - 866
  • [23] Concurrent expression of HP-NAP enhances antitumor efficacy of oncolytic vaccinia virus but not for Semliki Forest virus
    Ma, Jing
    Jin, Chuan
    Cancer, Matko
    Wang, Hai
    Ramachandran, Mohanraj
    Yu, Di
    MOLECULAR THERAPY-ONCOLYTICS, 2021, 21 : 356 - 366
  • [24] Systemic Injection of Oncolytic Vaccinia Virus Suppresses Primary Tumor Growth and Lung Metastasis in Metastatic Renal Cell Carcinoma by Remodeling Tumor Microenvironment
    Park, Jee Soo
    Lee, Myung Eun
    Jang, Won Sik
    Kim, Jongchan
    Park, Se Mi
    Oh, Keunhee
    Lee, Namhee
    Ham, Won Sik
    BIOMEDICINES, 2022, 10 (01)
  • [25] Apoptin enhances the oncolytic activity of vaccinia virus in vitro
    G. V. Kochneva
    I. N. Babkina
    T. A. Lupan
    A. A. Grazhdantseva
    P. V. Yudin
    G. F. Sivolobova
    A. N. Shvalov
    E. G. Popov
    I. V. Babkin
    S. V. Netesov
    P. M. Chumakov
    Molecular Biology, 2013, 47 : 733 - 742
  • [26] Apoptin enhances the oncolytic activity of vaccinia virus in vitro
    Kochneva, G. V.
    Babkina, I. N.
    Lupan, T. A.
    Grazhdantseva, A. A.
    Yudin, P. V.
    Sivolobova, G. F.
    Shvalov, A. N.
    Popov, E. G.
    Babkin, I. V.
    Netesov, S. V.
    Chumakov, P. M.
    MOLECULAR BIOLOGY, 2013, 47 (05) : 733 - 742
  • [27] T-cell Engager-armed Oncolytic Vaccinia Virus Significantly Enhances Antitumor Therapy
    Yu, Feng
    Wang, Xingbing
    Guo, Z. Sheng
    Bartlett, David L.
    Gottschalk, Stephen M.
    Song, Xiao-Tong
    MOLECULAR THERAPY, 2014, 22 (01) : 102 - 111
  • [28] Oncolytic vaccinia virus delivering tethered IL-12 enhances antitumor effects with improved safety
    Ge, Yan
    Wang, Haiyan
    Ren, Jinghua
    Liu, Weilin
    Chen, Lingjuan
    Chen, Hongqi
    Ye, Junjie
    Dai, Enyong
    Ma, Congrong
    Ju, Songguang
    Guo, Zong Sheng
    Liu, Zuqiang
    Bartlett, David L.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (01)
  • [29] T-Cell Engager-Armed Oncolytic Vaccinia Virus Significantly Enhances Antitumor Therapy
    Yu, Feng
    Gottschalk, Stephen M.
    Song, Xiao-Tong
    MOLECULAR THERAPY, 2013, 21 : S157 - S158
  • [30] Oncolytic vaccinia virus harboring CLEC2A gene enhances viral replication and antitumor efficacy
    Gao, Chunqing
    Ying, Qi
    Qiu, Yufeng
    Ren, Ningbo
    Chen, Kan
    Zhou, Yanrong
    Ye, Ting
    Li, Gongchu
    MOLECULAR THERAPY ONCOLOGY, 2024, 32 (03):
12345